Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of Time-Restricted Eating on Nonalcoholic Fatty Liver Disease
Xueyun Wei, Bingquan Lin, Yan Huang, et al.
JAMA Network Open (2023) Vol. 6, Iss. 3, pp. e233513-e233513
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
Frank Tacke, Paul Horn, Vincent Wai‐Sun Wong, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 3, pp. 492-542
Closed Access | Times Cited: 296
EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Frank Tacke, Paul Horn, Vincent Wai‐Sun Wong, et al.
Obesity Facts (2024) Vol. 17, Iss. 4, pp. 374-444
Open Access | Times Cited: 56
NAFLD and NASH: etiology, targets and emerging therapies
Shulin Wei, Li Wang, Paul C. Evans, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 3, pp. 103910-103910
Closed Access | Times Cited: 48
Effects of early, late and self-selected time-restricted eating on visceral adipose tissue and cardiometabolic health in participants with overweight or obesity: a randomized controlled trial
Manuel Dote‐Montero, Antonio Clavero‐Jimeno, Elisa Merchán-Ramírez, et al.
Nature Medicine (2025)
Closed Access | Times Cited: 2
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Children with Obesity: An Obesity Medicine Association (OMA) and Expert Joint Perspective 2025
Jennifer Panganiban, Mohit Kehar, Samar H. Ibrahim, et al.
Obesity Pillars (2025) Vol. 14, pp. 100164-100164
Open Access | Times Cited: 2
Effects of a 12‐Week Mediterranean‐Type Time‐Restricted Feeding Protocol in Patients With Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Randomised Controlled Trial—The ‘CHRONO‐NAFLD Project’
Sofia Tsitsou, Triada Bali, Magdalini Adamantou, et al.
Alimentary Pharmacology & Therapeutics (2025)
Open Access | Times Cited: 2
Intermittent fasting improves hepatic end points in nonalcoholic fatty liver disease: A systematic review and meta-analysis
Marcia Lange, Devika Nadkarni, Lily Martin, et al.
Hepatology Communications (2023) Vol. 7, Iss. 8
Open Access | Times Cited: 28
A microbial metabolite inhibits the HIF-2α-ceramide pathway to mediate the beneficial effects of time-restricted feeding on MASH
Yi Zhang, Xuemei Wang, Jun Lin, et al.
Cell Metabolism (2024) Vol. 36, Iss. 8, pp. 1823-1838.e6
Closed Access | Times Cited: 11
Practical Lifestyle Management of Nonalcoholic Fatty Liver Disease for Busy Clinicians
Shira Zelber‐Sagi, J. Bernadette Moore
Diabetes Spectrum (2024) Vol. 37, Iss. 1, pp. 39-47
Open Access | Times Cited: 9
Does early time-restricted eating reduce body weight and preserve fat-free mass in adults? A systematic review and meta-analysis of randomized controlled trials
Mengyu He, Bo Li, Ming Li, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2024) Vol. 18, Iss. 2, pp. 102952-102952
Closed Access | Times Cited: 8
Time Restricted Eating: A Valuable Alternative to Calorie Restriction for Addressing Obesity?
Maria Eugenia Parrotta, Luca Colangeli, Valeria SCIPIONE, et al.
Current Obesity Reports (2025) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Intermittent fasting regimens for metabolic dysfunction-associated steatotic liver disease: a systematic review and network meta-analysis of randomized controlled trials
Mohamed Abuelazm, Islam Mohamed, Ahmed Naeem, et al.
European Journal of Gastroenterology & Hepatology (2024) Vol. 36, Iss. 4, pp. 371-381
Closed Access | Times Cited: 7
Effects of time‐restricted eating on intrahepatic fat and metabolic health among patients with nonalcoholic fatty liver disease
Yan Deng, Xiaoming Liu, Yuzhe Sun, et al.
Obesity (2024) Vol. 32, Iss. 3, pp. 494-505
Closed Access | Times Cited: 6
Time-restricted feeding has a limited effect on hepatic lipid accumulation, inflammation and fibrosis in a choline-deficient high-fat diet-induced murine NASH model
Tomoyuki Sato, Katsutaka Oishi
PLoS ONE (2024) Vol. 19, Iss. 1, pp. e0296950-e0296950
Open Access | Times Cited: 5
Chrononutrition in the Prevention and Management of Metabolic Disorders: A Literature Review
Maria Mentzelou, Sousana Κ. Papadopoulou, Evmorfia Psara, et al.
Nutrients (2024) Vol. 16, Iss. 5, pp. 722-722
Open Access | Times Cited: 5
The impacts of Ramadan fasting for patients with non-alcoholic fatty liver disease (NAFLD): a systematic review
Xiaoxiao Lin, Guomin Wu, Jinyu Huang
Frontiers in Nutrition (2024) Vol. 10
Open Access | Times Cited: 4
Does time‐restricted eating add benefits to calorie restriction? A systematic review
Armin Ezzati, Christian McLaren, Carly Bohlman, et al.
Obesity (2024) Vol. 32, Iss. 4, pp. 640-654
Closed Access | Times Cited: 4
Unraveling the Health Benefits and Mechanisms of Time-Restricted Feeding: Beyond Caloric Restriction
Ruhan Wang, Yuxiao Liao, Yan Deng, et al.
Nutrition Reviews (2024)
Closed Access | Times Cited: 4
Beneficial effects of intermittent fasting on nonalcoholic fatty liver disease: a narrative review
Qingxuan Deng, Ruyue Lv, Haoqi Zou, et al.
Egyptian Liver Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Efficacy of intermittent fasting on improving liver function in individuals with metabolic disorders: a systematic review and meta-analysis
Mousa Khalafi, Sara K. Rosenkranz, Faeghe Ghasemi, et al.
Nutrition & Metabolism (2025) Vol. 22, Iss. 1
Open Access
Partially unraveling mechanistic underpinning and weight loss effects of time-restricted eating across diverse adult populations: A systematic review and meta-analyses of prospective studies
Duc Tran Quang, Khanh Nguyen Di, Linh Le Cu, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0314685-e0314685
Open Access
Effects of time restricted feeding combined with Lacto Ovo vegetarian diet on metabolic associated fatty liver disease management: a randomized clinical trial
Mahshad Shafiee, Amir Sadeghi, Fariba Taleghani, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
The efficacy of DASH combined with time-restricted feeding (16/8) on metabolic associated fatty liver disease management: a randomized controlled trial
Maryam Nilghaz, Amir Sadeghi, Glareh Koochakpoor, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Metabolic-Associated Steatotic Liver Disease (MASLD) and Type 2 Diabetes: Mechanisms, Diagnostic Approaches, and Therapeutic Interventions
Anastasia Ntikoudi, A Papachristou, Afroditi Tsalkitzi, et al.
Diabetology (2025) Vol. 6, Iss. 4, pp. 23-23
Open Access
Editorial: Chrononutrition and MASLD—It is About Time (Restricted Feeding)! Authors' Reply
Sofia Tsitsou, Magdalini Adamantou, Triada Bali, et al.
Alimentary Pharmacology & Therapeutics (2025)
Closed Access
Page 1 - Next Page

Scroll to top